These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

472 related items for PubMed ID: 24241494

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Identification of circulating microRNAs as diagnostic biomarkers for use in multiple myeloma.
    Jones CI, Zabolotskaya MV, King AJ, Stewart HJ, Horne GA, Chevassut TJ, Newbury SF.
    Br J Cancer; 2012 Dec 04; 107(12):1987-96. PubMed ID: 23169280
    [Abstract] [Full Text] [Related]

  • 4. [Expression of microRNA-221/222 in patients with monoclonal gammopathy of undetermined significance and multiple myeloma].
    Yang S, Wang W, Jin H, Zhong Y, Xie X.
    Zhejiang Da Xue Xue Bao Yi Xue Ban; 2016 May 25; 45(4):371-378. PubMed ID: 27868410
    [Abstract] [Full Text] [Related]

  • 5. Serum exosomal microRNAs as novel biomarkers for multiple myeloma.
    Zhang ZY, Li YC, Geng CY, Zhou HX, Gao W, Chen WM.
    Hematol Oncol; 2019 Oct 25; 37(4):409-417. PubMed ID: 31102419
    [Abstract] [Full Text] [Related]

  • 6. MicroRNA expression in multiple myeloma is associated with genetic subtype, isotype and survival.
    Chi J, Ballabio E, Chen XH, Kušec R, Taylor S, Hay D, Tramonti D, Saunders NJ, Littlewood T, Pezzella F, Boultwood J, Wainscoat JS, Hatton CS, Lawrie CH.
    Biol Direct; 2011 May 18; 6():23. PubMed ID: 21592325
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Aberrant Levels of miRNAs in Bone Marrow Microenvironment and Peripheral Blood of Myeloma Patients and Disease Progression.
    Wang W, Corrigan-Cummins M, Barber EA, Saleh LM, Zingone A, Ghafoor A, Costello R, Zhang Y, Kurlander RJ, Korde N, Roccaro AM, Ghobrial IM, Landgren O, Calvo KR.
    J Mol Diagn; 2015 Nov 18; 17(6):669-78. PubMed ID: 26433312
    [Abstract] [Full Text] [Related]

  • 11. MicroRNA-15a/16-1 cluster located at chromosome 13q14 is down-regulated but displays different expression pattern and prognostic significance in multiple myeloma.
    Li F, Xu Y, Deng S, Li Z, Zou D, Yi S, Sui W, Hao M, Qiu L.
    Oncotarget; 2015 Nov 10; 6(35):38270-82. PubMed ID: 26516702
    [Abstract] [Full Text] [Related]

  • 12. Molecular and biologic markers of progression in monoclonal gammopathy of undetermined significance to multiple myeloma.
    Mailankody S, Mena E, Yuan CM, Balakumaran A, Kuehl WM, Landgren O.
    Leuk Lymphoma; 2010 Dec 10; 51(12):2159-70. PubMed ID: 20958231
    [Abstract] [Full Text] [Related]

  • 13. The spectrum of somatic mutations in monoclonal gammopathy of undetermined significance indicates a less complex genomic landscape than that in multiple myeloma.
    Mikulasova A, Wardell CP, Murison A, Boyle EM, Jackson GH, Smetana J, Kufova Z, Pour L, Sandecka V, Almasi M, Vsianska P, Gregora E, Kuglik P, Hajek R, Davies FE, Morgan GJ, Walker BA.
    Haematologica; 2017 Sep 10; 102(9):1617-1625. PubMed ID: 28550183
    [Abstract] [Full Text] [Related]

  • 14. Quantitative analysis of CKS1B mRNA expression and copy number gain in patients with plasma cell disorders.
    Stella F, Pedrazzini E, Baialardo E, Fantl DB, Schutz N, Slavutsky I.
    Blood Cells Mol Dis; 2014 Sep 10; 53(3):110-7. PubMed ID: 24973170
    [Abstract] [Full Text] [Related]

  • 15. Low serum miR-19a expression as a novel poor prognostic indicator in multiple myeloma.
    Hao M, Zang M, Wendlandt E, Xu Y, An G, Gong D, Li F, Qi F, Zhang Y, Yang Y, Zhan F, Qiu L.
    Int J Cancer; 2015 Apr 15; 136(8):1835-44. PubMed ID: 25220540
    [Abstract] [Full Text] [Related]

  • 16. Immunohistochemical analysis of NOTCH1 and JAGGED1 expression in multiple myeloma and monoclonal gammopathy of undetermined significance.
    Skrtić A, Korać P, Krišto DR, Ajduković Stojisavljević R, Ivanković D, Dominis M.
    Hum Pathol; 2010 Dec 15; 41(12):1702-10. PubMed ID: 20800871
    [Abstract] [Full Text] [Related]

  • 17. Expression and significance of miR-21 in multiple myeloma patients.
    Wang JH, Zhou WW, Liu BX, Man DL, Yang ZD, Liu FR, Shang H.
    Genet Mol Res; 2016 Jan 22; 15(1):. PubMed ID: 26909911
    [Abstract] [Full Text] [Related]

  • 18. Quantitative polymerase Chain reaction profiling of microRNAs in peripheral lymph-monocytes from MGUS subjects.
    Avenoso A, Campo S, Scuruchi M, Mania M, Innao V, D'Ascola A, Mandraffino G, Allegra AG, Musolino C, Allegra A.
    Pathol Res Pract; 2021 Feb 22; 218():153317. PubMed ID: 33360970
    [Abstract] [Full Text] [Related]

  • 19. MicroRNAs regulate critical genes associated with multiple myeloma pathogenesis.
    Pichiorri F, Suh SS, Ladetto M, Kuehl M, Palumbo T, Drandi D, Taccioli C, Zanesi N, Alder H, Hagan JP, Munker R, Volinia S, Boccadoro M, Garzon R, Palumbo A, Aqeilan RI, Croce CM.
    Proc Natl Acad Sci U S A; 2008 Sep 02; 105(35):12885-90. PubMed ID: 18728182
    [Abstract] [Full Text] [Related]

  • 20. Prognostic role of circulating exosomal miRNAs in multiple myeloma.
    Manier S, Liu CJ, Avet-Loiseau H, Park J, Shi J, Campigotto F, Salem KZ, Huynh D, Glavey SV, Rivotto B, Sacco A, Roccaro AM, Bouyssou J, Minvielle S, Moreau P, Facon T, Leleu X, Weller E, Trippa L, Ghobrial IM.
    Blood; 2017 Apr 27; 129(17):2429-2436. PubMed ID: 28213378
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.